Kyle Rose
Urology · New Orleans, LANPI 1518311216
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (53.9%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Urogen Pharma, Inc. at 34.1% of the total.
Across 36 payments — averaging $249.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Urogen Pharma, Inc.$3K
- Janssen Global Services, LLC$2K
- Lumenis, Inc$2K
- Janssen Scientific Affairs, LLC$753
- Kerecis Limited$172
- Bioprotect Medical, Inc.$135
- plus $455 from 8 others
Across 10 payments — averaging $6676.60 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$67K
What the payments were for
- Consulting fees$4,84054%
- Speaking & faculty fees$2,00022%
- Food & beverage$2,13324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Urogen Pharma, Inc. | 10 | $3,060 |
| Janssen Global Services, LLC | 3 | $2,399 |
| Lumenis, Inc | 1 | $2,000 |
| Janssen Scientific Affairs, LLC | 10 | $753 |
| Kerecis Limited | 1 | $172 |
| Bioprotect Medical, Inc. | 1 | $135 |
| Boston Scientific | 2 | $125 |
| Pfizer | 1 | $100 |
| Johnson & Johnson | 2 | $92 |
| Progenics Pharmaceuticals, Inc. | 1 | $53 |
| Dendreon Pharmaceuticals LLC | 1 | $26 |
| Neotract Inc. | 1 | $20 |
| AbbVie | 1 | $20 |
| Merck | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$687
- JELMYTO$383
- Kerecis GraftGuide$172
- AKEEGA$146
- BIOPROTECT BALLOON IMPLANT SYSTEM$135
- Balversa$125
- XTANDI$100
How this compares
$8,973 in reported general payments places this provider in the 80th percentile of 199 urology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ciprofloxacin Hcl | 50 | $189 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $142 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 41 | $139 |
| Tamsulosin Hcl | 20 | $126 |
Paid to pharmacies, not to this prescriber.
Other urology in New Orleans
- Richard VanlangendonckNew Orleans$289K
- Wayne HellstromNew Orleans$183K
- Colin GoudelockeNew Orleans$124K
- Raju ThomasNew Orleans$67K
- Louis KraneNew Orleans$62K
- Jorge CasoNew Orleans$54K
- Lawrence JenkinsNew Orleans$33K
- Alexis ChesrowNew Orleans$17K
- Joanna TogamiNew Orleans$10K
- Neil BaumNew Orleans$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.